EC Healthcare's (HKG:2138) overall sales fell 4% in the six months ended Sept. 30, driven by declines across its medical and aesthetic services businesses in Hong Kong and mainland China.
The medical service provider said it expects to record overall sales of at least HK$2.10 billion for the half-year period, according to a Friday disclosure with the Hong Kong Exchange.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments